Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correction of Growth Hormone Deficiency in Patients With Chronic Heart Failure
NCT00591760Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Dec 2004
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, single-blind trial of somatotropin in heart failure (HF) and growth hormone deficiency (GHD) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: Peak Oxygen Consumption at 6 months. Started Dec 2004; status: completed.
02
Drugs
somatotropin
03
Conditions
heart failure (HF)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00591760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591760.